Differences in PGE₂ Production between Primary Human Monocytes and Differentiated Macrophages: Role of IL-1β and TRIF/IRF3

• Yukinori Endo ,

  Contributed equally to this work with: Yukinori Endo, Ksenia Blinova

  Affiliation Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America

  ⨯
• Ksenia Blinova ,

  Contributed equally to this work with: Yukinori Endo, Ksenia Blinova

  Affiliation Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America

  ⨯
• Tatiana Romantseva,

  Affiliation Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America

  ⨯
• Hana Golding,

  Affiliation Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America

  ⨯
• Marina Zaitseva

  * E-mail: marina.zaitseva@fda.hhs.gov

  Affiliation Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America

  ⨯